Form 4 holding
S.V.P., General Counsel
ARCA biopharma, Inc.
- Security class
- Common Stock
- Shares / value
- 50,970
- Estimated value
- $127,425
- Report date
- 14 Dec 2021
- Price
- $2.50
- Ownership
- Direct
Christopher David Ozeroff
Insider Reports History
- Reporting-owner location
- Broomfield, CO
- Latest reporting-owner signature
-
/s/ C. Jeffrey Dekker, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Christopher David Ozeroff
Form 4 holding
S.V.P., General Counsel
ARCA biopharma, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 27,500
- Estimated value
- Report date
- 14 Dec 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Christopher David Ozeroff
4
ORKA
ARCA biopharma, Inc.
- Report period
- 14 Dec 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 16 Dec 2021, 15:33
- Role
- S.V.P., General Counsel
- Next action
- Open filing details
4
ORKA
ARCA biopharma, Inc.
- Report period
- 22 Nov 2021
- Transactions
- 1
- Transaction value
- +$113,210
- Accepted by SEC
- 23 Nov 2021, 15:53
- Role
- S.V.P., General Counsel
- Next action
- Open filing details